Experimental Treatment for Genetic Amyotrophic Lateral Sclerosis Shows Potential in Trial
According to a story from BioSpace, the drug developer Biogen recently released interim results from a Phase 1/2 clinical trial. This clinical trial is testing the drug tofersen, which is…